Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 2,816 AGIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,816 | n/a |
| Jun 17, 2026 | KYNTRA BIO, INC. (KYNB) | Grant/Award | 7,000 | n/a |
| Jun 4, 2026 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 7,490 | n/a |
| May 29, 2026 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 80,000 | n/a |
| Jun 23, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,120 | n/a |
| Jun 6, 2025 | FIBROGEN INC (FGEN) | Grant/Award | 120,000 | n/a |
| May 30, 2025 | Neumora Therapeutics, Inc. (NMRA) | Disposition to Issuer | 95,586 | n/a |
| May 22, 2025 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 6,650 | n/a |
| Feb 18, 2025 | Neumora Therapeutics, Inc. (NMRA) | Disposition to Issuer | 95,586 | n/a |
| Jun 24, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/Award | 2,120 | n/a |